What it does
- Scaffold & analog design
- Qualitative ADME-Tox triage
- Ranked candidate portfolios
- Optimization campaign planning
MoleculeForge AI
Drug Discovery Copilot
From target to ranked therapeutic candidates — scaffold design, SAR logic, ADME-Tox triage, and optimization campaigns with explicit uncertainty and ethical guardrails.
Who it's forMedicinal Chemists · Comp Chem · Drug Discovery Teams
Built for
- Oncology
- Neurodegeneration
- Immunology
- Cardiovascular
Value
- Multi-objective ranking
- No wet-lab SOPs
- Dual-use refusal
- Validation-first mindset
How work changes
Same desk. Different first pass.
Traditional
Every page, every identifier, by hand.
Out
Manual scaffold brainstorming
Out
Siloed property predictions
Out
Ad hoc SAR meetings
Out
Late tox surprises
Out
Unclear next experiments
Out
Slow iteration cycles
MoleculeForge AI
The model takes the first pass. People take the exceptions.
Out
Clarify target & product profile
Out
Frame multi-objective design goal
Out
Propose & rank candidates
Out
ADME-Tox risk dashboard
Out
Recommend next assays (no SOPs)
Out
Iterate with new data critically
Fragmented design and late liability discoveryRanked, safety-aware portfolios with clear next data
Used for
Lead identification
Novel scaffolds and chemotypes with binding rationale and IP distance from known drugs.
Lead optimization
SAR-driven modifications balancing potency, selectivity, brain penetration, and hERG risk.
Library triage
Rank uploaded SMILES libraries with trade-off justification and de-risking experiment types.